The purpose of this study is to determine the safety of Zinc given at 90mg/d in conjunction with 2mg/d of copper in ALS patients.
Name: Zinc and Copper
Description: Optizinc 90 mg/d Copper 1 mgType: DrugZinc and Copper
Allocation: Randomized
Single Group Assignment
There is one SNP
Previous studies have shown that in ALS mutant G93A SOD transgenic mice, actual zinc supplementation delayed death. --- G93A ---